Basso Capital Management, L.P. Neurocrine Biosciences Inc Transaction History
Basso Capital Management, L.P.
- $106 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
642Shares Held
94.9MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$2.14 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.5 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$775 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$387 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$281 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.4B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...